Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Apr;25(2):182-186.
doi: 10.1177/1591019918809932. Epub 2018 Nov 4.

Very delayed discontinuation of telescoped Pipeline embolization devices: a case report

Affiliations
Case Reports

Very delayed discontinuation of telescoped Pipeline embolization devices: a case report

Manoj Bohara et al. Interv Neuroradiol. 2019 Apr.

Abstract

Background: Flow diversion with the Pipeline embolization device (PED) is a widely accepted treatment modality for aneurysm occlusion. Previous reports have shown no recanalization of aneurysms on long-term follow-up once total occlusion has been achieved.

Case description: We report on a 63-year-old male who had a large internal carotid artery cavernous segment aneurysm. Treatment with PED resulted in complete occlusion of the aneurysm. However, follow-up angiography at four years revealed recurrence of the aneurysm due to disconnection of the two PEDs placed in telescoping fashion.

Conclusion: Herein, we present the clinico-radiological features and discuss the possible mechanisms resulting in the recanalization of aneurysms treated with flow diversion.

Keywords: Aneurysm; Pipeline Embolization Device; flow diverter; recurrence.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Initial treatment of the left internal carotid artery cavernous segment large aneurysm (a) with two telescoped Pipeline embolization devices, resulting in complete occlusion of the aneurysm (b).
Figure 2.
Figure 2.
Follow-up digital subtraction angiography (a) and cone-beam computed tomography (b) at three-year follow-up showing no recurrence of the aneurysm.
Figure 3.
Figure 3.
Follow-up digital subtraction angiography (a) and cone-beam computed tomography (b) four years after the initial treatment showing recanalization of the aneurysm due to disconnection of the two Pipeline embolization devices.
Figure 4.
Figure 4.
The measurement of the extent of overlap of the two Pipeline embolization devices showing that the length of overlap after the initial treatment was 11.57 mm (a) whereas that at three-year follow-up was reduced to 1.15 mm (b).
Figure 5.
Figure 5.
Retreatment with addition of a Pipeline embolization device (PED, indicated by black arrow) to connect the detached PEDs ((a), cone-beam computed tomography), resulting in complete occlusion of the aneurysm after one month ((b), digital subtraction angiography).

Similar articles

Cited by

References

    1. Lylyk P, Miranda C, Ceratto R, et al. Curative endovascular reconstruction of cerebral aneurysms with the Pipeline embolization device: The Buenos Aires experience. Neurosurgery 2009; 64: 632–642. - PubMed
    1. Becske T, Brinjikji W, Potts MB, et al. Long-term clinical and angiographic outcomes following Pipeline embolization device treatment of complex internal carotid artery aneurysms: Five-year results of the Pipeline for Uncoilable or Failed Aneurysms trial. Neurosurgery 2017; 80: 40–48. - PubMed
    1. Nelson PK, Lylyk P, Szikora I, et al. The Pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 2011; 32: 34–40. - PMC - PubMed
    1. Daou B, Atallah E, Chalouhi N, et al. Aneurysms with persistent filling after failed treatment with the Pipeline embolization device. J Neurosurg. Epub ahead of print 4 May 2018. DOI: 10.3171/2017.12.JNS163090. - PubMed
    1. Trivelato FP, Ulhôa AC, Rezende MT, et al. Recurrence of a totally occluded aneurysm after treatment with a Pipeline embolization device. J Neurointerv Surg. Epub ahead of print 24 May 2018. DOI: 10.1136/neurintsurg-2018-013842.rep. - PubMed

Publication types

MeSH terms

Substances